Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Use of the femoral vein for intravenous access by injecting drug users (IDUs) (commonly called 'groin injecting') is a practice that is often observed but on which little is written in the literature. The purpose of this study was to describe self-reported data from a sample of groin injectors on the natural history and rationale regarding their groin injecting, to inform future research and the development of appropriate harm reduction strategies. Methods: A convenience sample of groin injectors willing to participate in a semi-structured interview were recruited through the Bristol Drugs Project Harm Reduction Service. The interviews were conducted over the period of one week. Data on transition to groin injecting, rationale for use and incidence of problems were collected. Results: Forty seven IDUs currently injecting in their femoral vein ('groin') were interviewed, 66% (n = 31) male and 34% (n = 16) female. Their mean age was 31 yrs (range 17 to 50 yrs; SD = 7.7). The mean length of time since first injecting episode was 9.6 yrs (range 6 mths to 30 yrs; SD = 7.0). The mean length of time since use of the groin began was 2.6 years (range 1 mth to 15 yrs; SD = 3.3). The mean length of time between first injection and first use of the groin was 7.0 yrs (SD = 7.0). One person had used no other area for venous access prior to using the groin, nine people had used one, nine people had used two, 10 people had used three, five people had used four and 13 people had used more than four areas. The main reason given for starting to inject in the groin was that 'no other sites were left'. However further discussion identified this meant no other convenient sites were accessible. Practises such as the rotation of injecting sites, as advocated in many harm reduction leaflets, were reported to be difficult and unreliable. The risk of missing the vein and subsequently losing the 'hit' was considered high. Use of the non-dominant hand to administer injections was problematic and deterred rotation between arms. The groin site was reported to be convenient, provide quick access, with little mess and less pain than smaller more awkward veins. The formation of sinuses over time facilitated continued use of the groin. Approximately two thirds of participants had experienced difficulty gaining IV access at their groin. Common problem included scar tissue occlusion, swelling and pain. Some reported infections and past history of deep vein thrombosis. Conclusion: Use of the groin was perceived to be convenient by the study group. Problems following safer injecting advice were identified, including dexterity difficulties leading to fear of losing the 'hit'. Health problems at the groin site did not deter use. These results suggest further qualitative work is needed to explore the difficulties in following safer injecting advice in more detail and inform the development of more appropriate advice. Further quantitative work is necessary to establish the prevalence of groin injecting amongst IDUs and the incidence of associated problems. There is a need for a longitudinal study to examine the relationship between injecting technique and loss of patency of veins. If protective factors could be identified, evidence-based safer injecting advice could be established to preserve peripheral veins and reduce use of the groin site, which is high risk and associated with serious adverse consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cherubin, C. E., & Sapira, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00009 · Cited by 238
Physical injecting sites among injecting drug users in Sydney, Australia
Darke, S., Ross, J., & Kaye, S. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00161-7 · Cited by 111
Injecting‐related harm and treatment‐seeking behaviour among injecting drug users
MORRISON, A., ELLIOTT, L., & GRUER, L. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02853.x · Cited by 102 · cited 1×
“The physical health complications of injecting drug use are well documented in the literature (e.g.[ 1-6 ]).”
Background
Cited by
Wilson, W. R., Bower, T. C., Creager, M. A., Amin-Hanjani, S., O’Gara, P. T., Lockhart, P. B., Darouiche, R. O., Ramlawi, B., Derdeyn, C. P., Bolger, A. F., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000457 · Cited by 572
Crack–heroin speedball injection and its implications for vein care: qualitative study
Rhodes, T., Briggs, D., Kimber, J., Jones, S., & Holloway, G. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01969.x · Cited by 75
Rhodes, T., Stoneman, A., Hope, V., Hunt, N., Martin, A., & Judd, A. (2006) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.02.011 · Cited by 51
Injecting drug use, the skin and vasculature
Robertson, R., Broers, B., & Harris, M. (2021) · Addiction · doi:10.1111/add.15283 · Cited by 42
Hope, V. D., Parry, J. V., Ncube, F., & Hickman, M. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.11.003 · Cited by 41
“The findings presented here, and those from previous studies undertaken in the United Kingdom (Maliphant & Scott, 2005; Hickman, et al., 2007; Harris & Rhodes, 2012; Hope, Cullen, Croxford, Parry, & Ncube, 2014), indicate that there is considerable room to improve injection practice and hygiene through, for example, r…”
Influential
Metadata
- Authors
- Maliphant, J., & Scott, J.
- Venue
- Harm Reduction Journal
- Published
- 2005-04-15
- Volume
- 2
- Issue
- 1
- Pages
- 6-6
- ISSN
- 1477-7517 (ISSN-L)
- OpenAlex
- W2158775879
- Cited by
- 60
- References
- 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.